Studies showed that c-Met plays a significant role in cancer progression in different cancers [13,14,20,111,112]; moreover, dysregulation of the c-Met pathway was demonstrated in CRC, although still little is known about its genetic mutations in CRC [110,111,113]. Here, MET is linked to cancer.